Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Enzyme replacement treatment in type 1 and type 3 Gaucher's disease.

Lancet (London, England) - 17 Dec 1994

Bembi B, Zanatta M, Carrozzi M, Baralle F, Gornati R, Berra B, Agosti E

Abstract excerpt

The development of intravenous enzyme-replacement treatment for Gaucher's disease has changed life expectancy in cases without neurological involvement (type 1). The effects in patients with neurological involvement are unknown. We treated 12 Italian patients, types 1 (9) and 3 (3), with intraven...

Topics

Adolescent
Adult
Alleles
Child
Child, Preschool
Drug Administration Schedule
Female
Follow-Up Studies
Gaucher Disease
Glucosylceramidase
Humans
Infusions, Intravenous
Male

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Middle Aged

Source

Identifiers

PMID: 7996964
DOI: 10.1016/s0140-6736(94)90462-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-7996964-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Enzyme replacement treatment in type 1 and type 3 Gaucher's disease.PMID 7996964Read ↗

Baseline characteristics and outcome in Romanian patients with Gaucher disease type 1.Semantic proximity Read ↗

Enzyme replacement therapy of infantile Gaucher disease.Semantic proximity Read ↗

Pediatric Gaucher experience in South Marmara region of Turkey.Semantic proximity Read ↗

A French experience of type 3 Gaucher disease: Phenotypic diversity and neurological outcome of 10 patients.Semantic proximity Read ↗

[Enzyme replacement therapy for Gaucher disease introduced in late adulthood].Semantic proximity Read ↗

Enzyme therapy for Gaucher disease: the first 5 yearsSemantic proximity Read ↗

Adult-type Gaucher disease in children: genetics, clinical features and enzyme replacement therapy.Semantic proximity Read ↗

[Response criteria for enzyme substitution in Gaucher disease].Semantic proximity Read ↗

[Alglucerase treatment of type I Gaucher's disease. Preliminary results in Spain. Spanish Group on Gaucher's Disease].Semantic proximity Read ↗

Clinical and genetic study of Japanese patients with type 3 Gaucher disease.Semantic proximity Read ↗

Low-dose high-frequency enzyme replacement therapy prevents fractures without complete suppression of painful bone crises in patients with severe juvenile onset type I Gaucher disease.Semantic proximity Read ↗

Low frequency maintenance therapy with imiglucerase in adult type I Gaucher disease: a prospective randomized controlled trial.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.